Your search returned 29 results.

Sort
Results
1.
Does a negative 124I pre-therapy scan in patients with elevated thyroglobulin predict a negative131I post-therapy scan? Updated results. MedStar authors:
  • Khorjekar, Gauri
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Khorjekar G, Van Nostrand D, Moreau S, Burman K, Chennupati S, Bandaru V, Wartofsky L
Local accession number:
  • 2013_2
2.
Evaluation of lymphoid organs by FDG PET/CT in high risk sarcoma patients receiving immunotherapy (IT) with tumor vaccine compared with tumor vaccine and IL-7. MedStar authors:
  • Khorjekar, Gauri
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Millo C, Khorjekar G, Merchant M, Sioka C, Mackall C
Local accession number:
  • 2013_16
3.
Guidelines for the indications for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_161
4.
Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_235
5.
Guidelines for the prescribed activity for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_236
6.
Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Guan H, Van Nostrand D, Li Y, Teng W, Khorjekar G
Local accession number:
  • 2013_7
7.
Guidelines for the prescribed activity for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_162
8.
Number of Foci of Functioning Thyroid Tissue Remaining after Thyroidectomy for Differentiated Thyroid Cancer: Institutional Experience. MedStar authors:
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Mete, Mihriye
  • Van Nostrand, Douglas
PMID:
  • 28553178
Year: 2017
Citation:
  • World Journal of Nuclear Medicine. 16(2):122-125, 2017 Apr-Jun
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Khorjekar G, Kulkarni K, Mete M, Van Nostrand D
9.
Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit MedStar authors:
  • Duong, Eric
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Duong E, Khorjekar G, Van Nostrand D
Local accession number:
  • 2013_7
10.
124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors:
  • Atkins, Frank
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G
Local accession number:
  • 2013_166
11.
124I-NaI PET/CT based 3-D radiobiological Dosimetry (3D-RD) for 131I-NaI therapy of metastatic well-differentiated thyroid cancer. MedStar authors:
  • Atkins, Frank
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Atkins F, Khorjekar G, Orquiza MD
Local accession number:
  • 2013_2
12.
Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey MedStar authors:
  • Hall, Jordan
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Hall J, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
Local accession number:
  • 2013_7
13.
Characterization of salivary gland side effects secondary to 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey for intermediate and long term results MedStar authors:
  • Hall, Jordan
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Hall J, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
Local accession number:
  • 2013_7
14.
Evaluation of lithium as adjunctive treatment of 131I therapy for differentiated thyroid cancer: an educational exhibit MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Van Nostrand D, Khorjekar G, Elboga U, Guan H, Wartofsky L
Local accession number:
  • 2013_7
15.
#Alpharadinr #(Xofigor) in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors:
  • Duong, Eric
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Duong E, Orquiza M, Khorjekar G, Van Nostrand D
Local accession number:
  • 2013_159
16.
Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors:
  • Duong, Eric
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Duong E, Orquiza M, Khorjekar G, Van Nostrand D
Local accession number:
  • 2013_233
17.
Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results. MedStar authors:
  • Hall, Jordan
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza MH, Hall JP, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
Local accession number:
  • 2013_2
18.
A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey. MedStar authors:
  • Brennan, Michael T
  • Hall, Jordan
  • Khorjekar, Gauri
  • Van Nostrand, Douglas
  • Wu, Di
  • Zeymo, Alexander
Year: 2017
Citation:
  • Unpublished 2017/10/03
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bloom G
  • Brennan MT
  • Hall J
  • Khorjekar G
  • McIver B
  • Van Nostrand D
  • Wu D
  • Zeymo A
Local accession number:
  • A2017_050
19.
Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for Metastatic Differentiated Thyroid Cancer (DTC). MedStar authors:
  • Atkins, Frank
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Khorjekar G, Orquiza MD, Atkins F, Mete M, Garcia C, Wartofsky L, Van Nostrand D
Local accession number:
  • 2013_2
20.
Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer. MedStar authors:
  • Atkins, Frank
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D
Local accession number:
  • 2013_16
21.
Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC) MedStar authors:
  • Atkins, Frank
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D
Local accession number:
  • 2013_4
22.
Characterization of sialoadenitis after administration of continous sialogogues during the day and night After 131 I therapy. MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Orquiza, Michael D
  • Schneider, Mark
  • Wartofsky, Leonard
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Endocrinology
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L
Local accession number:
  • 2013_165
23.
Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors:
  • Atkins, Francis
  • Burman, Kenneth D
  • Khorjekar, Gauri R
  • Kulkarni, Kanchan
  • Moreau, Shari
  • Orquiza, Michael H
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Endocrinology
  • Medicine/General Internal Medicine
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L
Local accession number:
  • 2014.1_132
24.
Characterization of Sialoadenitis (SA) after administration of continuous Sialogogues (SGs) during the day and night after 131I therapy (tx). MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Orquiza, Michael D
  • Schneider, Mark
  • Wartofsky, Leonard
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
Local accession number:
  • 2013_230
25.
Characterization of sialoadenitis (SA) after administration of continuous sialogogues (SGs) during the day and night after 131I therapy (tx) MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Orquiza, Michael D
  • Schneider, Mark
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D
Local accession number:
  • 2013_7
26.
Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?. MedStar authors:
  • Atkins, Francis
  • Burman, Kenneth
  • Garcia, Carlos
  • Khorjekar, Gauri R
  • Mete, Mihriye
  • Moreau, Shari
  • O'Neil, Jeff
  • Orquiza, Michael H
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 24820222
Citation:
  • Thyroid. 24(9):1394-9, 2014 Sep.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Atkins FB, Burman K, Garcia C, Khorjekar GR, Mete M, Moreau S, O'Neil J, Orquiza MH, Van Nostrand D, Wartofsky L
27.
Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri R
  • Kulkarni, Kanchan
  • Orquiza, Michael H
  • Schneider, M
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Endocrinology
  • Medicine/General Internal Medicine
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D
Local accession number:
  • 2014.1_133
28.
Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri R
  • Kulkarni, Kanchan
  • Orquiza, Michael H
  • Schneider, M
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Endocrinology
  • Medicine/General Internal Medicine
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D
Local accession number:
  • 2014.1_134
29.
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET.[Erratum appears in J Nucl Med. 2012 May;53(5):830] MedStar authors:
  • Atkins, Frank B
  • Burman, Kenneth D
  • Chennupati, Shyam P
  • Kharazi, Pejman
  • Khorjekar, Gauri R
  • Mete, Mihriye
  • Moreau, Shari
  • O'Neil, Jeff
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 22315442
Year: 2012
Citation:
  • Journal of Nuclear Medicine. 53(3):359-62, 2012 Mar.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Atkins FB, Burman KD, Chennupati SP, Kharazi P, Khorjekar GR, Mete M, Moreau S, O'Neil J, Van Nostrand D, Wartofsky L
Pages

Powered by Koha